Age-related changes in D1 and D2 receptor mRNA expression in postmortem human putamen with and without multiple small infarcts

Neuroscience Letters

Volumn 243, Issue 1-3, 1998, Pages 37-40

  Tohgi, Hideo ^a   Utsugisawa, Kimiaki ^a   Yoshimura, Masahiro ^b   Nagane, Yuriko ^a   Mihara, Masatoshi ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL EXAMINER S OFFICE   (Japan)

Author keywords

Aging; D1 dopamine receptor; D2 dopamine receptor; Ischemia; Reverse transcription polymerase chain reaction; Striatum

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; MESSENGER RNA;

ADULT; AGED; AGING; ARTICLE; BRAIN INFARCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPERKINESIA; MALE; PRIORITY JOURNAL; PUTAMEN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTINS; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBRAL INFARCTION; DNA PRIMERS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PUTAMEN; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RNA, MESSENGER;

EID: 0031909939     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00080-9     Document Type: Article

References (25)

1. Alexander G.E., Crutcher M.D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 13:1990;266-271.
2. Cash R., Raisman R., Ploska A., Agid Y. Dopamine D1 receptor and cyclic AMP-dependent phosphorylation in Parkinson's disease. J. Neurochem. 49:1987;1075-1083.
3. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13:1990;281-285.
4. Di Chiara G., Morelli M., Consolo S. Modulatory functions of neurotransmitters in the striatum: ACh-dopamine-NMDA interactions. Trends Neurosci. 17:1994;228-233.
5. Du Breuil R.M., Patel J.M., Mendelow B.V. Quantitation of β-actin-specific mRNA transcripts using xeno-competitive PCR. PCR Methods Appl. 3:1993;57-59.
6. Ferré S., Fredholm B.B., Morelli M., Popoli P., Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 20:1997;482-487.
7. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 15:1992;133-139.
8. 2 dopamine receptor. Proc. Natl. Acad. Sci. USA. 86:1989;9762-9766.
9. 2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J. Neurosci. 15:1995;5222-5237.
10. Lai H., Bowden D.M., Horita A. Age-related decreases in dopamine receptors in the caudate nucleus and putamen of the rhesus monkey (macaca mulatta). Neurobiol. Aging. 8:1987;45-49.
11. 2 dopamine receptors associated with inhibition of dopamine release from rat neostriatum are independent of cyclic AMP. Neurosci. Lett. 71:1986;192-196.
12. 3H1 flupehnazine as a dopamine receptor ligand. Abstr. Soc. Neurosci. 10:1984;445.
13. 3H-piflutixol. Eur J. Pharmacol. 105:1984;171-174.
14. Onali P., Olianas M.C., Gessa G.L. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum. Mol. Pharmacol. 28:1985;138-145.
15. 1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease. Eur. J. Pharmacol. 114:1985;235-237.
16. 2 receptors and uptake sites: a quantitative autoradiographic study. J. Neurochem. 57:1991;1951-1961.
17. Rinne J.O., Rinne J.K., Laakso K., Lonberg P., Rinne U.K. Dopamine D-1 receptors in the parkinsonian brain. Brain Res. 359:1985;306-310.
18. 2 receptors. Brain Res. 508:1990;349-352.
19. Severson J.A., Randall P.K. D-2 dopamine receptors in aging mouse striatum: determination of high- and low-affinity agonist binding sites. J. Pharmacol. Exp. Ther. 233:1985;361-368.
20. 1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study. J. Neurol. Neurosurg. Psychiatry. 56:1993;467-472.
21. Tohgi H., Utsugisawa K., Yoshimura M., Yamagata M., Nagane Y., Saitoh K. Reduction in the ratio of β-preprotachykinin to preproenkephalin messenger RNA expression in postmortem human putamen during aging and in patients with status lacunaris. Implications for the susceptibility to parkinsonism. Brain Res. 768:1997;86-90.
22. Wong D.F., Wagner H.N. Jr., Dannals R.F., Links J.M., Frost J.J., Ravert H.T., Wilson A.A., Rosenbaum A.E., Gjedde A., Douglass K.H., Petronis J.D., Folstein M.F., Toung J.K.T., Burns H.D., Kuhar M.J. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science. 226:1984;1393-1396.
23. Young III W.S., Bonner T.I., Brann M.R. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. Natl. Acad. Sci. USA. 83:1986;9827-9831.
24. 2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience. 65:1995;709-730.
25. 1 dopamine receptors. Nature. 347:1990;76-80.